超导管与低风险患者的外科动脉置换:更新的元分析
Tomonari M Shimoda1, Yoshihisa Miyamoto2, Shinichi Fukuhara3
1United States Naval Hospital Yokosuka, Yokosuka, Japan.
The American journal of cardiology
|July 14, 2025
概括
过导管大动脉置换 (TAVR) 在患有大动脉狭窄症的低风险患者中显示出比手术大动脉置换 (SAVR) 早期生存益处. 然而,需要长期数据来确认这种初始优势是否会随着时间的推移而持续下去.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 大动脉狭窄症 (AS) 管理需要仔细选择跨导管大动脉置换 (TAVR) 和手术大动脉置换 (SAVR).
- 长期结果数据对于指导低风险AS患者的治疗决策至关重要.
- 最近的随机对照试验 (RCT) 和中期结果需要进行文献审查.
研究的目的:
- 在低风险AS患者中系统评估和比较TAVR与SAVR的中期死亡结果.
- 综合来自RCT的证据,为有关TAVR和SAVR选择的临床实践提供信息.
主要方法:
- 在低风险AS患者中对TAVR和SAVR进行比较的RCT的系统识别.
- 从卡普兰-梅尔曲线中重建的时间到事件数据的元分析.
- 用分层的考克斯模型,基准分析和受限平均存活时间 (RMST) 分析来评估中期死亡率.
主要成果:
- 包括7个涉及5740名患者的RCT (TAVR:2,927人;SAVR:2,813人).
- 在5年后,TAVR与全因死亡率降低有关 (HR 0.83;95% CI 0.70-1.00).
- 里程碑式的分析显示,在程序后的第一年,TAVR的生存益处显著,但此后这种差异减少了. 在5年后的RMST分析有利于TAVR (p = 0.01).
结论:
- 通过导管的大动脉置换 (TAVR) 在与外科大动脉置换 (SAVR) 相比,在患有大动脉狭窄的低风险患者中显示出早期生存优势.
- 这种早期益处的长期临床意义仍然不确定.
- 进一步的长期数据对于该患者群体的最终临床决策至关重要.
相关概念视频
Aortic Regurgitation III: Medical Management
47
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
47
Mitral Stenosis III: Medical Management
27
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
27
Mitral Regurgitation III: Medical Management
34
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
34
Mitral Valve Prolapse II: Assessment and Management
44
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
44


